Retraction
Kinesin family member 2C aggravates the progression of hepatocellular carcinoma and interacts with competing endogenous RNA
Paper Information
Record ID:
34423
Author(s):
Journal:
Publication Date:
February 14, 2020
Retraction Date:
December 03, 2021
(4.0 years years ago)
Subjects:
Institution:
Department of Liver Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (11)
11
Total Citations3
Post-Retraction(27.3%)
8
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
231
Days since retraction (latest)
Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas
Fei Ding, Jinping Li, Yong Zhang et al. (5 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Jul 2022
10 citations
10 citations
231 days after retraction
Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma
Lin Wang, Jun Zhao, Cancan Zhu et al. (6 authors)
Genes
Open Access
Published: Apr 2022
10 citations
10 citations
146 days after retraction
Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras/MAPK signaling pathway and epithelial-to-mesenchymal transition
Shutian Mo, Dalang Fang, Shuqi Zhao et al. (16 authors)
Annals of Translational Medicine
Open Access
Published: Jan 2022
28 citations
28 citations
55 days after retraction
Kinesin family member 2C promotes hepatocellular carcinoma growth and metastasis via activating MEK/ERK pathway
Qian Ding, Caihua Jiang, Yajing Zhou et al. (7 authors)
Bioscience Biotechnology and Biochemistry
Published: Sep 2021
13 citations
13 citations
87 days before retraction
KIF2C promotes the proliferation of hepatocellular carcinoma cells<i> in vitro</i> and <i>in vivo</i>
Zhenya Gao, Huanxia Jia, Fang Yu et al. (5 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Aug 2021
15 citations
15 citations
123 days before retraction
Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
Fang Wang, Peter Breslin S.J., Wei Qiu
Liver Research
Open Access
Published: Jun 2021
7 citations
7 citations
163 days before retraction
Silenced lncRNA DDX11-AS1 or up-regulated microRNA-34a-3p inhibits malignant phenotypes of hepatocellular carcinoma cells via suppression of TRAF5
Gangqiang Ding, Yanli Zeng, Dongqiang Yang et al. (8 authors)
Cancer Cell International
Open Access
Published: Mar 2021
12 citations
12 citations
256 days before retraction
Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis
Weihua Zhu, Lixin Ru, Zhenchao Ma
Frontiers in Oncology
Open Access
Published: Mar 2021
10 citations
10 citations
266 days before retraction
Novel Prognostic Markers for Liver Hepatocellular Carcinoma and Their Roles in Immune Infiltration of the Tumor Microenvironment
Meihai Deng, Hao Liang, Kunpeng Hu et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Jan 2021
1 citation
1 citation
330 days before retraction
CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells
Xiaoxue Jiang, Libo Xing, Yingjie Chen et al. (15 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: Nov 2020
39 citations
39 citations
381 days before retraction
KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma
Wei Shi, Miaomiao Dai, Chi Zhang et al. (13 authors)
Protein & Cell
Open Access
Published: Aug 2020
102 citations
102 citations
487 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
4.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025